SNY
Sanofi ADR
NASDAQ: SNY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$46.58
+1.19% today
Updated 2026-04-30
Market cap
$110.28B
P/E ratio
19.84
P/S ratio
2.33x
EPS (TTM)
$2.32
Dividend yield
—
52W range
$43 – $53
Volume
3.5M
Sanofi ADR (SNY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
16.00%
Operating margin
20.00%
ROE
6.43%
ROA
4.65%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $29.49B | $4.01B | 74.27% | 19.43% | 13.58% |
| 2007 | $29.21B | $5.26B | 74.08% | 20.24% | 18.02% |
| 2008 | $28.82B | $3.85B | 74.54% | 15.25% | 13.36% |
| 2009 | $30.75B | $5.26B | 74.37% | 20.70% | 17.12% |
| 2010 | $34.04B | $5.47B | 72.39% | 19.20% | 16.06% |
| 2011 | $35.06B | $5.65B | 69.01% | 16.72% | 16.10% |
| 2012 | $35.96B | $4.89B | 69.14% | 17.88% | 13.59% |
| 2013 | $31.29B | $3.72B | 67.08% | 15.92% | 11.88% |
| 2014 | $32.00B | $4.39B | 68.03% | 18.95% | 13.72% |
| 2015 | $34.86B | $4.29B | 68.68% | 16.13% | 12.30% |
| 2016 | $34.70B | $4.71B | 69.16% | 18.82% | 13.57% |
| 2017 | $36.22B | $8.42B | 67.94% | 16.02% | 23.24% |
| 2018 | $35.68B | $4.31B | 67.95% | 13.11% | 12.07% |
| 2019 | $37.63B | $2.75B | 68.17% | 8.11% | 7.32% |
| 2020 | $37.37B | $12.29B | 67.46% | 37.77% | 32.90% |
| 2021 | $39.17B | $6.22B | 68.72% | 20.74% | 15.89% |
| 2022 | $40.56B | $8.37B | 70.71% | 25.05% | 20.64% |
| 2023 | $41.62B | $5.40B | 69.66% | 16.72% | 12.98% |
| 2024 | $44.29B | $5.56B | 70.18% | 16.38% | 12.55% |
| 2025 | $46.72B | $7.81B | 72.34% | 13.58% | 16.72% |